Among PTGs with reported biochemical interactions with NADs (based on the Drug Targets Commons (DTC)41), expression of potassium channels, glutamate receptors and cannabinoid receptors were enriched in glioblastoma cells, whereas other target classes showed broader expression patterns (Extended Data Fig. 4b). The gene discussed is KCNA3; the disease is glioblastoma.